Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma (DBCOND0030859)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00608361	Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery	Dasatinib	treatment	1	completed
NCT01254578	Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers	Lenalidomide	treatment	1	completed
NCT00082888	Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma	Tipifarnib	treatment	2	completed
NCT01567709	Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma	Alisertib Vorinostat	treatment	1	completed
NCT01403415	Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Asparaginase Escherichia coli Dexamethasone Menthol Methopterin Methotrexate Mitoxantrone Pegaspargase Sirolimus Sulfate ion Temsirolimus Vincristine	treatment	1	completed
NCT02797470	Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant	Beta-D-Glucose Carmustine Cytarabine Etoposide Mechlorethamine	treatment	1 / 2	active_not_recruiting
NCT04803201	Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma	Azacitidine Cyclophosphamide Doxorubicin Duvelisib Etoposide Prednisone Vincristine	treatment	2	recruiting
NCT01466881	Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma	Alisertib	treatment	2	completed
NCT01326702	Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors	Bendamustine Rituximab Veliparib	treatment	1 / 2	completed
NCT01787409	Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency	No drug interventions	treatment	Not Available	recruiting
NCT03113500	Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma	Beta-D-Glucose Brentuximab vedotin Cortisone Cyclophosphamide Daunorubicin Doxorubicin Etoposide Prednisone	treatment	2	active_not_recruiting
NCT02342782	Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma	Basiliximab Carmustine Cytarabine Etoposide Melphalan Yttrium Y-90	treatment	1	active_not_recruiting
NCT03501576	Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma	Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated) Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated)	Not Available	Not Available	recruiting